Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million

Reuters

2025/12/02

Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million

Mabion SA reported third quarter (Q3) 2025 revenue of PLN 4.1 million, representing a multiple of nearly 7 times year-on-year growth. For the first nine months (9M) of 2025, revenue amounted to PLN 10.1 million, down 84.4 percent year-on-year. The net result for Q3 2025 was a loss of PLN 10.8 million, an improvement of 34 percent compared to the same period last year. EBITDA for Q3 2025 stood at minus PLN 8.4 million, also an improvement of 34.7 percent year-on-year. Cash at the end of Q3 2025 totaled PLN 4.6 million, declining by PLN 6.2 million quarter-on-quarter. The company secured additional bridge financing of PLN 18 million after the balance sheet date. Mabion SA's revenue in Q3 2025 was primarily driven by services provided to Novavax and other CDMO projects. The company maintained high cost discipline and reported marginal capital expenditures of PLN 0.2 million in the quarter. Mabion SA continues to focus on technology, operational excellence, and portfolio diversification, with expectations to reach break-even and transition to profitability by the end of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabion SA published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2588035267"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588035267\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588035267?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588035267","market":"nz","top_or_hot":-1,"title":"Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Mabion SA reported third quarter (Q3) 2025 revenue of PLN 4.1 million, representing a multiple of nearly 7 times year-on-year growth. For the first nine months (9M) of 2025, revenue amounted to PLN 10.1 million, down 84.4 percent year-on-year. The net result for Q3 2025 was a loss of PLN 10.8 million, an improvement of 34 percent compared to the same period last year. EBITDA for Q3 2025 stood at minus PLN 8.4 million, also an improvement of 34.7 percent year-on-year. Cash at the end of Q3 2025 totaled PLN 4.6 million, declining by PLN 6.2 million quarter-on-quarter. The company secured additional bridge financing of PLN 18 million after the balance sheet date. Mabion SA's revenue in Q3 2025 was primarily driven by services provided to Novavax and other CDMO projects. The company maintained high cost discipline and reported marginal capital expenditures of PLN 0.2 million in the quarter. Mabion SA continues to focus on technology, operational excellence, and portfolio diversification, with expectations to reach break-even and transition to profitability by the end of 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabion SA published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMabion SA Q3 revenue surges sevenfold to PLN 4.1 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-02 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Mabion SA reported third quarter (Q3) 2025 revenue of PLN 4.1 million, representing a multiple of nearly 7 times year-on-year growth. For the first nine months (9M) of 2025, revenue amounted to PLN 10.1 million, down 84.4 percent year-on-year. The net result for Q3 2025 was a loss of PLN 10.8 million, an improvement of 34 percent compared to the same period last year. EBITDA for Q3 2025 stood at minus PLN 8.4 million, also an improvement of 34.7 percent year-on-year. Cash at the end of Q3 2025 totaled PLN 4.6 million, declining by PLN 6.2 million quarter-on-quarter. The company secured additional bridge financing of PLN 18 million after the balance sheet date. Mabion SA's revenue in Q3 2025 was primarily driven by services provided to Novavax and other CDMO projects. The company maintained high cost discipline and reported marginal capital expenditures of PLN 0.2 million in the quarter. Mabion SA continues to focus on technology, operational excellence, and portfolio diversification, with expectations to reach break-even and transition to profitability by the end of 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabion SA published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL82C4jm:1","article_id":"2588035267","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588035267","pubTimestamp":1764666296,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Mabion SA reported third quarter  2025 revenue of PLN 4.1 million, representing a multiple of nearly 7 times year-on-year growth. For the first nine months  of 2025, revenue amounted to PLN 10.1 million, down 84.4 percent year-on-year. The net result for Q3 2025 was a loss of PLN 10.8 million, an improvement of 34 percent compared to the same period last year. EBITDA for Q3 2025 stood at minus PLN 8.4 million, also an improvement of 34.7 percent year-on-year. Cash at the end of Q3 2025 totaled PLN 4.6 million, declining by PLN 6.2 million quarter-on-quarter. The company secured additional bridge financing of PLN 18 million after the balance sheet date. Mabion SA's revenue in Q3 2025 was primarily driven by services provided to Novavax and other CDMO projects. The company maintained high cost discipline and reported marginal capital expenditures of PLN 0.2 million in the quarter. Mabion SA continues to focus on technology, operational excellence, and portfolio diversification, with expe","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4547":"WSB热门概念","NVAX":"诺瓦瓦克斯医药","BK4588":"碎股","BK4568":"美国抗疫概念","BK4585":"ETF&股票定投概念"},"translate_title":"Mabion SA第三季度收入猛增七倍至410万兹罗提","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Mabion SA Q3 revenue surges sevenfold to PLN 4.1 million\n    \n\n        Mabion SA reported third quarter (Q3) 2025 revenue of PLN 4.1 million, representing a multiple of nearly 7 times year-on-year growth. For the first nine months (9M) of 2025, revenue amounted to PLN 10.1 million, down 84.4 percent year-on-year. The net result for Q3 2025 was a loss of PLN 10.8 million, an improvement of 34 percent compared to the same period last year. EBITDA for Q3 2025 stood at minus PLN 8.4 million, also an improvement of 34.7 percent year-on-year. Cash at the end of Q3 2025 totaled PLN 4.6 million, declining by PLN 6.2 million quarter-on-quarter. The company secured additional bridge financing of PLN 18 million after the balance sheet date. Mabion SA's revenue in Q3 2025 was primarily driven by services provided to Novavax and other CDMO projects. The company maintained high cost discipline and reported marginal capital expenditures of PLN 0.2 million in the quarter. Mabion SA continues to focus on technology, operational excellence, and portfolio diversification, with expectations to reach break-even and transition to profitability by the end of 2026.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mabion SA published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}